Crescent Biopharma (CBIO) Q2 2025 Earnings

14MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2025
-5
-3.35
-1.69
-0.04

Details

Expected EPS
-5
Actual EPS
-4.32155
Surprise EPS
0.68
Surprise Percent
+13.57%

Description

Crescent Biopharma (CBIO) has reported earnings of -4.32155 per share for Q2 2025.

0 Comments

Share your thoughts